Barclays Maintains Overweight on Evolus, Raises Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad maintains an Overweight rating on Evolus (NASDAQ:EOLS) and raises the price target from $16 to $20.
September 13, 2024 | 3:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Balaji Prasad has reaffirmed an Overweight rating on Evolus and increased the price target from $16 to $20, indicating a positive outlook for the stock.
The increase in price target from $16 to $20 by Barclays suggests a positive outlook for Evolus, likely leading to a short-term increase in stock price as investors react to the analyst's confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100